ITU Tier 1+ #7: Psychiatric Information Theory (K_psych)

Tier 1+ Pass-1.5 paper 7 of 45. ITU-derived psychiatry on neurotransmitter + circuit + behavior + env + genetics. Defines K_psych = -log ρ_psych as the operator-algebraic modular Hamiltonian on H_neurotransmitter ⊗ H_circuit ⊗ H_behavior ⊗ H_environment ⊗ H_genetics. K_psych inherits from K_QG via the CLPW 2023 type II crossed-product specialised to this scale. Numerical results. Depression prevalence WHO 280M, SSRI Prozac 1987, MDMA-AT Lykos FDA rejected 2024.8.9, Cobenfy KarXT BMS 2024.9.27 first non-D2 antipsychotic. Topics covered. Psychiatric diagnosis DSM-5-TR 2022, ketamine/esketamine 2019, psilocybin Compass Phase 3, MDMA-AT 2024.8.9 rejected, RDoC NIMH 2010. 45-vertex polytope #7 top couplings: #1 AI (0.92), #5 Cancer (0.85), #27 Microbiome (0.85), #38 Anthro (0.85). Ten falsifiable predictions: P_avg=0.68: arXiv 2026 (0.90 S), Psilocybin FDA approval 2027 (0.65 M), Suicide rate reduction 20% by 2030 (0.45 W). Pass-2 roadmap: ~$1.8M: Psych analytics ($600K) + Lean Mathlib ($200K) + Trial partnerships ($1M). Copyright © 2026 Munehiro Terada / Roboken. Licensed under CC-BY-4.0.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-19
DOI
https://doi.org/10.5281/zenodo.20271123
Primary Topic
Psychedelics and Drug Studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

ITU Tier 1+ #7: Psychiatric Information Theory (K_psych)

Munehiro Terada
Zenodo (CERN European Organization for Nuclear Research)
Psychedelics and Drug Studies
preprint

ITU Tier 1+ #7: Psychiatric Information Theory (K_psych)

Munehiro Terada
preprint en

Abstract

Tier 1+ Pass-1.5 paper 7 of 45. ITU-derived psychiatry on neurotransmitter + circuit + behavior + env + genetics. Defines K_psych = -log ρ_psych as the operator-algebraic modular Hamiltonian on H_neurotransmitter ⊗ H_circuit ⊗ H_behavior ⊗ H_environment ⊗ H_genetics. K_psych inherits from K_QG via the CLPW 2023 type II crossed-product specialised to this scale. Numerical results. Depression prevalence WHO 280M, SSRI Prozac 1987, MDMA-AT Lykos FDA rejected 2024.8.9, Cobenfy KarXT BMS 2024.9.27 first non-D2 antipsychotic. Topics covered. Psychiatric diagnosis DSM-5-TR 2022, ketamine/esketamine 2019, psilocybin Compass Phase 3, MDMA-AT 2024.8.9 rejected, RDoC NIMH 2010. 45-vertex polytope #7 top couplings: #1 AI (0.92), #5 Cancer (0.85), #27 Microbiome (0.85), #38 Anthro (0.85). Ten falsifiable predictions: P_avg=0.68: arXiv 2026 (0.90 S), Psilocybin FDA approval 2027 (0.65 M), Suicide rate reduction 20% by 2030 (0.45 W). Pass-2 roadmap: ~$1.8M: Psych analytics ($600K) + Lean Mathlib ($200K) + Trial partnerships ($1M). Copyright © 2026 Munehiro Terada / Roboken. Licensed under CC-BY-4.0.

Zenodo (CERN European Organization for Nuclear Research)
Stroke Association (GB)
Good health and well-being
Psychedelics and Drug Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.